National Institutes of Health: Colitis, Ulcerative trials

The registry lists 10 Colitis, Ulcerative studies with National Institutes of Health as lead sponsor. 3 are open to participants now and 3 have results posted.

Phase 1 3Phase 2 5No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Longitudinal Immunophenotyping of Patients With Inflammatory Bowel DiseaseRecruitingNCT07619547
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 1
• Immune Regulation in Ulcerative Colitis or Crohn s DiseaseRecruitingNCT00001184
• Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in RemissionCompletedNCT02365480Phase 1Results posted
• Trichuris Suis Ova Treatment in Left-sided Ulcerative ColitisTerminatedNCT01953354Phase 2Results posted
• Interferon-beta1a (AVONEX) Treatment of Ulcerative ColitisCompletedNCT00048347Phase 2Results posted
• The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel DiseaseWithdrawnNCT05652491
• Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory ComplicationsCompletedNCT05104723Phase 1/2
• Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous DiseaseCompletedNCT03983837Phase 2
• Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative ColitisCompletedNCT00004810Phase 2